These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26763447)

  • 21. ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP.
    Nitschke Y; Yan Y; Buers I; Kintziger K; Askew K; Rutsch F
    Exp Mol Med; 2018 Oct; 50(10):1-12. PubMed ID: 30369595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy.
    Edouard T; Chabot G; Miro J; Buhas DC; Nitschke Y; Lapierre C; Rutsch F; Alos N
    Eur J Pediatr; 2011 Dec; 170(12):1585-90. PubMed ID: 21932012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates: from softening water to treating PXE.
    Moore SN; Tanner SB; Schoenecker JG
    Cell Cycle; 2015; 14(9):1354-5. PubMed ID: 25894689
    [No Abstract]   [Full Text] [Related]  

  • 24. Catalysis-Independent ENPP1 Protein Signaling Regulates Mammalian Bone Mass.
    Zimmerman K; Liu X; von Kroge S; Stabach P; Lester ER; Chu EY; Srivastava S; Somerman MJ; Tommasini SM; Busse B; Schinke T; Carpenter TO; Oheim R; Braddock DT
    J Bone Miner Res; 2022 Sep; 37(9):1733-1749. PubMed ID: 35773783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?
    Hildebrand S; Cunningham J
    Bone; 2021 Jan; 142():115751. PubMed ID: 33188959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercementosis Associated with ENPP1 Mutations and GACI.
    Thumbigere-Math V; Alqadi A; Chalmers NI; Chavez MB; Chu EY; Collins MT; Ferreira CR; FitzGerald K; Gafni RI; Gahl WA; Hsu KS; Ramnitz MS; Somerman MJ; Ziegler SG; Foster BL
    J Dent Res; 2018 Apr; 97(4):432-441. PubMed ID: 29244957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lead Acetate-Injected Mice is an Animal Model for Extrapolation of Calcifying Response to Humans Due to Low Involvement of Bone Resorption.
    Morikane S; Ishida K; Ashizawa N; Taniguchi T; Matsubayashi M; Kurita N; Kobashi S; Iwanaga T
    Calcif Tissue Int; 2024 Sep; 115(3):315-327. PubMed ID: 38951181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum.
    Bartstra JW; de Jong PA; Kranenburg G; Wolterink JM; Isgum I; Wijsman A; Wolf B; den Harder AM; Mali WPTM; Spiering W
    Atherosclerosis; 2020 Jan; 292():37-41. PubMed ID: 31756632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro.
    Tenenbaum HC; Torontali M; Sukhu B
    Bone; 1992; 13(3):249-55. PubMed ID: 1637572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium and Anti-phosphate Treatment with Bisphosphonates for Generalised Arterial Calcification of Infancy: A Case Report.
    Dursun F; Atasoy Öztürk T; Güven S; Kırmızıbekmez H; Seymen Karabulut G; Kalın S; Sözeri B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):311-318. PubMed ID: 30525344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutics Development for Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders: Update 2020.
    Luo H; Li Q; Cao Y; Uitto J
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy.
    Miyai K; Ariyasu D; Numakura C; Yoneda K; Nakazato H; Hasegawa Y
    Bone Rep; 2015 Dec; 3():57-60. PubMed ID: 28377967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic modulation of nephrocalcinosis in mouse models of ectopic mineralization: the Abcc6(tm1Jfk) and Enpp1(asj) mutant mice.
    Li Q; Chou DW; Price TP; Sundberg JP; Uitto J
    Lab Invest; 2014 Jun; 94(6):623-32. PubMed ID: 24732453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into Pathomechanisms and Treatment Development in Heritable Ectopic Mineralization Disorders: Summary of the PXE International Biennial Research Symposium-2016.
    Uitto J; Li Q; van de Wetering K; Váradi A; Terry SF
    J Invest Dermatol; 2017 Apr; 137(4):790-795. PubMed ID: 28340679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy.
    Otero JE; Gottesman GS; McAlister WH; Mumm S; Madson KL; Kiffer-Moreira T; Sheen C; Millán JL; Ericson KL; Whyte MP
    J Bone Miner Res; 2013 Feb; 28(2):419-30. PubMed ID: 22972716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy.
    Albright RA; Stabach P; Cao W; Kavanagh D; Mullen I; Braddock AA; Covo MS; Tehan M; Yang G; Cheng Z; Bouchard K; Yu ZX; Thorn S; Wang X; Folta-Stogniew EJ; Negrete A; Sinusas AJ; Shiloach J; Zubal G; Madri JA; De La Cruz EM; Braddock DT
    Nat Commun; 2015 Dec; 6():10006. PubMed ID: 26624227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.
    Kim S; Seiryu M; Okada S; Kuroishi T; Takano-Yamamoto T; Sugawara S; Endo Y
    Eur J Pharmacol; 2013 Jan; 699(1-3):14-22. PubMed ID: 23201069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Lomashvili KA; Monier-Faugere MC; Wang X; Malluche HH; O'Neill WC
    Kidney Int; 2009 Mar; 75(6):617-25. PubMed ID: 19129793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles.
    Keuth J; Nitschke Y; Mulac D; Riehemann K; Rutsch F; Langer K
    Eur J Pharm Biopharm; 2020 May; 150():108-119. PubMed ID: 32151731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.